Each individual isoform of the dopamine D2 receptor protects from lactotroph hyperplasia

Molecular Endocrinology

Volumn 27, Issue 6, 2013, Pages 953-965

  Radl, Daniela ^a   De Mei, Claudia ^a   Chen, Eric ^a   Lee, Hyuna ^a   Borrelli, Emiliana ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE 2 RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROLACTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL FUNCTION; CELL HYPERPLASIA; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HORMONE SYNTHESIS; HYPERPROLACTINEMIA; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROLACTIN SECRETING CELL; PROTEIN FUNCTION;

ANIMALS; CARCINOGENESIS; CELL LINE; ESTRADIOL; ESTROGENS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; GENE EXPRESSION; HYPERPLASIA; LACTOTROPHS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PHOSPHORYLATION; PITUITARY GLAND; PROTEIN ISOFORMS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, DOPAMINE D2; SIGNAL TRANSDUCTION;

EID: 84877914783     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2013-1008     Document Type: Article

References (42)

1. Ben-Jonathan N, Hnasko R. Dopamine as a prolactin (PRL) inhibitor. Endocr Rev. 2001;22:724-763
2. Radl DB, Ferraris J, Boti V, Seilicovich A, Sarkar DK, Pisera D. Dopamine-induced apoptosis of lactotropes is mediated by the short isoform of D2 receptor. PloS One. 2011;6:e18097
3. Saiardi A, Bozzi Y, Baik JH, Borrelli E. Antiproliferative role of dopamine: loss of D2 receptors causes hormonal dysfunction and pituitary hyperplasia. Neuron. 1997;19:115-126
4. Molitch ME. Prolactinoma in pregnancy. Best Pract Res Clin Endocrinol Metab. 2011;25:885-896
5. Colao A, Savastano S. Medical treatment of prolactinomas. Nat Rev Endocrinol. 2011;7:267-278
6. Gillam MP, Molitch ME, Lombardi G, Colao A. Advances in the treatment of prolactinomas. Endocr Rev. 2006;27:485-534
7. Kelly MA, Rubinstein M, Asa SL, et al. Pituitary lactotroph hyperplasia and chronic hyperprolactinemia in dopamine D2 receptordeficient mice. Neuron. 1997;19:103-113
8. Borgundvaag B, George SR. Dopamine inhibition of anterior pituitary adenylate cyclase is mediated through the high-affinity state of the D2 receptor. Life Sci. 1985;37:379-386
9. Ishida M, Mitsui T, Yamakawa K, et al. Involvement of cAMP response element-binding protein in the regulation of cell proliferation and the prolactin promoter of lactotrophs in primary culture. Am J Physiol Endocrinol Metab. 2007;293:E1529-E1537
10. Montmayeur JP, Borrelli E. Transcription mediated by a cAMPresponsive promoter element is reduced upon activation of dopamine D2 receptors. Proc Natl Acad Sci USA. 1991;88:3135-3139
11. Iaccarino C, Samad TA, Mathis C, Kercret H, Picetti R, Borrelli E. Control of lactotrop proliferation by dopamine: essential role of signaling through D2 receptors and ERKs. Proc Natl Acad Sci USA. 2002;99:14530-14535
12. Beaulieu JM, Gainetdinov RR, Caron MG. The Akt-GSK-3 signaling cascade in the actions of dopamine. Trends Pharmacol Sci. 2007;28:166-172
13. Cakir M, Grossman AB. Targeting MAPK (Ras/ERK) and PI3K/ Akt pathways in pituitary tumorigenesis. Expert Opin Ther Targets. 2009;13:1121-1134
14. Dworakowska D, Wlodek E, Leontiou CA, et al. Activation of RAF/MEK/ERK and PI3K/AKT/mTOR pathways in pituitary adenomas and their effects on downstream effectors. Endocr Relat Cancer. 2009;16:1329-1338
15. Montmayeur JP, Bausero P, Amlaiky N, Maroteaux L, Hen R, Borrelli E. Differential expression of the mouse D2 dopamine receptor isoforms. FEBS Lett. 1991;278:239-243
16. Montmayeur JP, Guiramand J, Borrelli E. Preferential coupling between dopamine D2 receptors and G-proteins. Mol Endocrinol. 1993;7:161-170
17. Guiramand J, Montmayeur JP, Ceraline J, Bhatia M, Borrelli E. Alternative splicing of the dopamine D2 receptor directs specificity of coupling to G-proteins. J Biol Chem. 1995;270:7354-7358
18. Usiello A, Baik JH, Rouge-Pont F, et al. Distinct functions of the two isoforms of dopamine D2 receptors. Nature. 2000;408:199-203
19. Baik JH, Picetti R, Saiardi A, et al. Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptors. Nature. 1995; 377:424-428
20. Asa SL, Kelly MA, Grandy DK, Low MJ. Pituitary lactotroph adenomas develop after prolonged lactotroph hyperplasia in dopamine D2 receptor-deficient mice. Endocrinology. 1999;140:5348-5355
21. Picetti R, Saiardi A, Abdel Samad T, Bozzi Y, Baik JH, Borrelli E. Dopamine D2 receptors in signal transduction and behavior. Crit Rev Neurobiol. 1997;11:121-142
22. Bertolino A, Fazio L, Di Giorgio A, et al. Genetically determined interaction between the dopamine transporter and the D2 receptor on prefronto-striatal activity and volume in humans. J Neurosci. 2009;29:1224-1234
23. Doi M, Yujnovsky I, Hirayama J, et al. Impaired light masking in dopamine D2 receptor-null mice. Nat Neurosci. 2006;9:732-734
24. Beaulieu JM, Sotnikova TD, Marion S, Lefkowitz RJ, Gainetdinov RR, Caron MG. An Akt/-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior. Cell. 2005; 122:261-273
25. Beaulieu JM, Tirotta E, Sotnikova TD, et al. Regulation of Akt signaling by D2 and D3 dopamine receptors in vivo. J Neurosci. 2007;27:881-885
26. Borrelli E, Heyman RA, Arias C, Sawchenko PE, Evans RM. Transgenic mice with inducible dwarfism. Nature. 1989;339:538-541
27. Sarkar DK. Genesis of prolactinomas: studies using estrogentreated animals. Front Horm Res. 2006;35:32-49
28. Toledano Y, Zonis S, Ren SG, Wawrowsky K, Chesnokova V, Melmed S. Estradiol partially recapitulates murine pituitary cell cycle response to pregnancy. Endocrinology. 2012;153:5011-5022
29. Takahashi S. Intrapituitary regulatory system of proliferation of mammotrophs in the pituitary gland. Zool Sci. 2004;21:601-611
30. Hentges S, Boyadjieva N, Sarkar DK. Transforming growth factor-β3 stimulates lactotrope cell growth by increasing basic fibroblast growth factor from folliculo-stellate cells. Endocrinology. 2000;141:859-867
31. Oomizu S, Takeuchi S, Takahashi S. Stimulatory effect of insulin'ke growth factor I on proliferation of mouse pituitary cells in serum-free culture. J Endocrinol. 1998;157:53-62
32. Albert PR. G protein preferences for dopamine D2 inhibition of prolactin secretion and DNA synthesis in GH4 pituitary cells. Mol Endocrinol. 2002;16:1903-1911
33. Senogles SE. The D2 dopamine receptor isoforms signal through distinct Giα proteins to inhibit adenylyl cyclase. A study with sitedirected mutant Giα proteins. J Biol Chem. 1994;269:23120-23127
34. Liu YF, Civelli O, Grandy DK, Albert PR. Differential sensitivity of the short and long human dopamine D2 receptor subtypes to protein kinase C. J Neurochem. 1992;59:2311-2317
35. Conrad KE, Oberwetter JM, Vaillancourt R, Johnson GL, Gutierrez- Hartmann A. Identification of the functional components of the Ras signaling pathway regulating pituitary cell-specific gene expression. Mol Cell Biol. 1994;14:1553-1565
36. Romano D, Magalon K, Ciampini A, Talet C, Enjalbert A, Gerard C. Differential involvement of the Ras and Rap1 small GTPases in vasoactive intestinal and pituitary adenylyl cyclase activating polypeptides control of the prolactin gene. J Biol Chem. 2003;278: 51386-51394
37. Romano D, Magalon K, Pertuit M, et al. Conditional overexpression of the wild-type Gs as the gsp oncogene initiates chronic extracellularly regulated kinase 1/2 activation and hormone hypersecretion in pituitary cell lines. Endocrinology. 2007;148:2973-2983
38. Banihashemi B, Albert PR. Dopamine-D2S receptor inhibition of calcium influx, adenylyl cyclase, and mitogen-activated protein kinase in pituitary cells: distinct Gα and Gβγ requirements. Mol Endocrinol. 2002;16:2393-2404
39. Liu JC, Baker RE, Chow W, Sun CK, Elsholtz HP. Epigenetic mechanisms in the dopamine D2 receptor-dependent inhibition of the prolactin gene. Mol Endocrinol. 2005;19:1904-1917
40. Liu JC, Baker RE, Sun C, Sundmark VC, Elsholtz HP. Activation of Go-coupled dopamine D2 receptors inhibits ERK1/ERK2 in pituitary cells. A key step in the transcriptional suppression of the prolactin gene. J Biol Chem. 2002;277:35819-35825
41. Kanasaki H, Fukunaga K, Takahashi K, Miyazaki K, Miyamoto E. Involvement of p38 mitogen-activated protein kinase activation in bromocriptine-induced apoptosis in rat pituitary GH3 cells. Biol Reprod. 2000;62:1486-1494
42. Kievit P, Lauten JD, Maurer RA. Analysis of the role of the mitogenactivated protein kinase in mediating cyclic-adenosine 3',5'-monophosphate effects on prolactin promoter activity. Mol Endocrinol. 2001;15:614-624.